Influence of Caloric Restriction & Resveratrol in the Sirtuin System in

Status Recruiting

Clinical Trial Summary

Women have a natural protection that gives them greater longevity. One hypothesis most commonly used is the estrogen protection in the premenopausal period. However many studies of various forms of hormone replacement therapy proved ineffective in promoting additional protection for women. Thus, it is discussed other ways of protection associated with longevity in women. Of these, the sirtuin system was found in several animal studies to be associated with longevity. This system also showed, through the involvement of several metabolic pathways, an important protection against the process of atherosclerosis. But the activity of this system in humans is unknown and if it is more active in women than in men. The study's main objectives are to analyze this system in healthy 24 women and 24 men aged 55 to 65 years, and their influence on the main metabolic pathways related to longevity and the process of atherosclerosis. The research protocol includes analysis of the influence of sirtuin (SIRT1) in vascular reactivity, lipid profile, antioxidant capacity, markers of inflammation and homeostasis, before and after the interventions with caloric restriction or resveratrol administration. It is expected of this study mechanistic conclusion for longevity and possible clinical applications in the mechanism of atherosclerosis prevention.

Clinical Trial Description

After a washout period of 15 days without medication, men and women will be randomized to the group of calorie restriction or resveratrol so that in 24 individuals (12 women and 12 men) will be given a hypocaloric diet (1000 calories per day) and the remaining 24 individuals (12 women and 12 men), a daily pill of 500mg of resveratrol. In the two moments, after the washout period and before the intervention (baseline) and after 30 days of intervention (final) will evaluate the clinical, laboratory and vascular reactivity of all subjetcs. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01668836
Study type	Interventional
Source	InCor Heart Institute
Contact	Antônio de Pádua Mansur, PHD
Phone	00551126615387
Email	antonio.mansur@incor.usp.br
Status	Recruiting
Phase	N/A
Start date	August 2012
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04896619` - Cholesterol Effects of Kori-tofu Proteins	N/A
Completed	`NCT01737164` - Effect of Age on Glucose and Lipid Metabolism	N/A
Completed	`NCT05629403` - Exclusive Breastfeeding Improves Puerperal Glucose Metabolism in Pregnant Women With Gestational Diabetes Mellitus and Links to Lipids Composition
Withdrawn	`NCT03047538` - Fixed Combination for Lipid and Blood Pressure Control	Phase 4
Withdrawn	`NCT02270164` - The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study	N/A
Completed	`NCT01968720` - Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia	Phase 2
Completed	`NCT01435382` - A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia	Phase 1
Completed	`NCT00707746` - Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects	Phase 2
Active, not recruiting	`NCT01803776` - The Physical Activity and Nutrition in Children (PANIC) Study	N/A
Active, not recruiting	`NCT05618756` - CBD, Nutrient Metabolism and Energy Intake	N/A
Completed	`NCT05558488` - The Effect of a Meatless,Keto Restrictive Diet on Body Composition,Strength Capacity,Oxidative Stress,Immune Response	N/A
Recruiting	`NCT04948008` - Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia	Phase 2/Phase 3
Completed	`NCT03898505` - Clinical Investigation on the Safety of Avocado Pulp Lipids	Early Phase 1
Completed	`NCT01311375` - Omega 3 in Intervention Spinal Cord Injured People	Phase 2/Phase 3
Terminated	`NCT01963650` - Natural History Study of Children With Metachromatic Leukodystrophy
Not yet recruiting	`NCT06060886` - Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis	Phase 4
Completed	`NCT03976479` - Body Composition, Nutritional and Cardiovascular Status and Lifestyle Factors of Adults Who Are on Plant-Based Diet
Completed	`NCT02243969` - Alpha-linolenic Acid and Blood Pressure	N/A
Completed	`NCT01874132` - Study of the Long-term Effects of Exercise on Heath Indicators in Older People	N/A
Completed	`NCT00477594` - Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms